We received a grant from Novartis Czech Republic and purchased a new ultrasound machine. We will use this device to perform preventive monitoring of blood flow through cerebral arteries in patients with sickle cell anaemia. In case of deterioration of this flow, we will be able to intervene early by administering blood transfusions and starting treatment with hydroxyurea. In this way, we will be able to minimize the occurrence of stroke in children with sickle cell anemia - a serious and life-threatening complication for our patients. The ultrasound will then also be used to diagnose acute complications in our patients, as well as other patients at the John Paul II Clinic in Buikwe. Thank you!!